Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
[1] Patients with well-controlled hypothyroidism secondary to Hashimoto's disease who are stable on levothyroxine replacement therapy may be considered for Wegovy treatment, provided they meet the eligibility criteria for weight management therapy
Semaglutide Semaglutide 2.4mg 68 14.9 17.4% Tirzepatide 2539 Tirzepatide 72 15 22.5% Liraglutide 3.0 mg Liraglutide 56 63.2% 5% 27.1% 25% GLP-1 4 GLP-1 L L GLP-1 L L L L GLP-1 L L L L GLP-1 L GLP-1 L 5 GLP-1 4 GLP-1 L GLP-1 (kg) 30 35 ml 2 3 BMR 7 9 GhrelinLeptin GLP-1 QA GLP-1 Q Q GLP-1 Q Q QGLP-1 Q QBMI BMI 30 kg/m BMI 27 30 kg/m 335 986 37 Top 15
They should be used cautiously in patients with gastro-oesophageal reflux disease
Long-term electrolyte management Electrolyte needs change as your GLP-1 treatment progresses
US$ 21.97
US$ 23.83
US$ 22.85
US$ 22.85
US$ 25.74
